These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2659474)

  • 21. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [When do we use which drugs? Procedures for the treatment of rheumatoid arthritis].
    Bolten WW
    Pharm Unserer Zeit; 2003; 32(5):405-12. PubMed ID: 14526461
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
    [No Abstract]   [Full Text] [Related]  

  • 24. Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
    Emery P; Luqmani R; Gordon C
    Br J Clin Pract; 1994; 48(2):82-6. PubMed ID: 7912952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450
    [No Abstract]   [Full Text] [Related]  

  • 26. [The pharmacological effect of nonsteroid anti-inflammatory agents and their interaction with blood plasma proteins].
    Lutsevich AN; Bender KI; Kupchikov VV
    Eksp Klin Farmakol; 1992; 55(2):68-74. PubMed ID: 1422462
    [No Abstract]   [Full Text] [Related]  

  • 27. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis].
    Tumanova IG; Sigidin IaA
    Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of cyclosporin A (Sandimmun) on the level of soluble interleukin-2 receptors in rheumatoid arthritis].
    Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina BN
    Ter Arkh; 1997; 69(8):19-21. PubMed ID: 9381385
    [No Abstract]   [Full Text] [Related]  

  • 29. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F; Murdaca G; Ghio M; Indiveri F
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease-modifying drugs in rheumatoid arthritis.
    Rahman A; Ahmed S; Underwood M
    Practitioner; 2001 Dec; 245(1629):1018-25. PubMed ID: 11771221
    [No Abstract]   [Full Text] [Related]  

  • 31. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excess mortality in rheumatoid arthritis--is it the disease or the drugs?
    Symmons D
    J Rheumatol; 1995 Dec; 22(12):2200-2. PubMed ID: 8835548
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe neutropenia due to naproxen therapy in rheumatoid arthritis: a case report and review of literature.
    Kalksma R; Jansen TL; Bruyn GA
    Neth J Med; 2002 Aug; 60(7):289-91. PubMed ID: 12430576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity of antirheumatic drugs.
    Lehmann T; Day RO; Brooks PM
    Med J Aust; 1997 Apr; 166(7):378-83. PubMed ID: 9137286
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of inflammation mediators and antirheumatic drugs on the production of superoxide anion (O2-) by polymorphonuclear cells in normals and rheumatoid arthritis].
    Pellegrini R; Lalumera M; Berti C; Morozzi G; Marcolongo R
    Boll Soc Ital Biol Sper; 1982 Apr; 58(7):392-6. PubMed ID: 6282292
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacia and Pfizer on the CLASS trial: criticism doesn't give a fair picture of the results].
    Andersson T; Frösing R
    Lakartidningen; 2002 Oct; 99(41):4086. PubMed ID: 12451957
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of drug use in rheumatoid arthritis.
    Roger L
    J Rheumatol; 2001 Jun; 28(6):1463-4; author reply 1464-5. PubMed ID: 11409144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.